Nobel laureate Stanley Prusiner will talk about his prize-winning research about prions during the UCSF Osher Mini Medical School for the Public on April 16.
November 16, 2011
Our mature brains may not be so old and inflexible after all. Scientists are discovering that the human brain can improve its performance to counter the consequences of cognitive impairment and even the trauma of stroke-induced brain damage.
November 14, 2011
October 25, 2011
Former Wall Street executive Gordon Murray, a former patient UCSF, wrote a book after battling brain cancer for more than a year, knowing that he had only a few months to live when he started it.
October 24, 2011
A study by researchers at the University of Mississippi Medical Center and UCSF shows that rats given a popularly prescribed antidepressant during development exhibit brain abnormalities and behaviors characteristic of autism spectrum disorders.
October 14, 2011
The only medication currently approved for stroke treatment – tissue plasminogen activator (tPA), which dissolves blood clots – is associated with an increased risk of bleeding in the brain, particularly among patients with hyperglycemia (high blood sugar).
October 12, 2011
Bryan Stow is now recovering after being treated for a severe brain injury at the UCSF-affiliated San Francsico General Hospital and Trauma Center, which recently became the first hospital in the country to be certified for a Traumatic Brain Injury Program by the Joint Commission.
September 28, 2011
Brain tumor specimens taken from neurosurgery cases at the University of California, San Francisco (UCSF) Medical Center has given scientists a new window on the transformation that occurs as healthy brain cells begin to form tumors
September 26, 2011
Gallo neuroscientist Linda Wilbrecht, PhD, receives President’s Early Career Award, in recognition of her studies on the effects of drug use and stress on the adolescent brain, aimed at developing strategies to mitigate drug dependence.
September 12, 2011
An enzyme that appears to play a role in controlling the brain's response to nicotine and alcohol in mice might be a promising target for a drug that simultaneously would treat nicotine addiction and alcohol abuse in people.